tradingkey.logo
tradingkey.logo
Search

Arcus Biosciences Inc

RCUS
Add to Watchlist
28.190USD
-0.040-0.14%
Close 07-31 16:00ETQuotes delayed by 15 min
3.55BMarket Cap
LossP/E TTM

RCUS Financials

See Arcus Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Arcus Biosciences Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.90
Revenue / Forecast
--/23.41M
Period
FY2025 Earnings
Revenue(YoY)
247.00M
-4.26%
EPS(YoY)
-3.29
-4.64%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
10.32%-1.02
12.83%-0.89
-25.93%-1.27
100.00%0.00
-2353.04%-1.14
4.73%-1.03
-5.76%-1.01
0.36%-1.02
95.77%-0.05
-16.16%-1.08
---0.95
---1.02
---1.10
---0.93
---2.78
----
----
----
----
----
Revenue
-39.29%17.00M
26.92%33.00M
-45.83%26.00M
310.26%160.00M
-80.69%28.00M
-16.13%26.00M
50.00%48.00M
34.48%39.00M
480.00%145.00M
-7.89%31.00M
-4.71%32.00M
8.37%29.00M
38.85%25.00M
-90.51%33.66M
254.94%33.58M
182.83%26.76M
90.31%18.00M
3636.68%354.50M
-85.34%9.46M
440.63%9.46M
Net Profit
-14.29%-128.00M
-12.77%-106.00M
-46.74%-135.00M
100.00%0.00
-2700.00%-112.00M
-16.05%-94.00M
-29.58%-92.00M
-24.00%-93.00M
95.00%-4.00M
-20.08%-81.00M
-9.37%-71.00M
-12.56%-75.00M
-17.66%-80.00M
-124.15%-67.46M
16.74%-64.92M
12.29%-66.63M
6.34%-67.99M
638.77%279.37M
-4379.64%-77.97M
-68.55%-75.97M
Net Margin
-88.24%-752.94%
11.15%-321.21%
-170.90%-519.23%
100.00%0.00%
-14400.00%-400.00%
-38.37%-361.54%
13.62%-191.67%
7.79%-238.46%
99.14%-2.76%
-30.36%-261.29%
---221.88%
---258.62%
---320.00%
---200.43%
---254.70%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
141.56%10.03%
108.24%8.69%
168.02%10.06%
--9.02%
--4.15%
--4.17%
--3.75%
----
----
--0.00%
----
----
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
-39.29%17.00M
26.92%33.00M
-45.83%26.00M
310.26%160.00M
-80.69%28.00M
-16.13%26.00M
50.00%48.00M
34.48%39.00M
480.00%145.00M
-7.89%31.00M
-4.71%32.00M
8.37%29.00M
38.85%25.00M
-90.51%33.66M
254.94%33.58M
182.83%26.76M
90.31%18.00M
3636.68%354.50M
-85.34%9.46M
440.63%9.46M
Operating profit
-9.84%-134.00M
-10.68%-114.00M
-35.24%-142.00M
92.45%-8.00M
-3150.00%-122.00M
-13.19%-103.00M
-31.25%-105.00M
-27.71%-106.00M
104.65%4.00M
-22.24%-91.00M
-15.28%-80.00M
-20.32%-83.00M
-28.01%-86.00M
-126.47%-74.44M
11.18%-69.40M
9.40%-68.98M
7.65%-67.18M
640.77%281.27M
-5134.54%-78.14M
-67.79%-76.14M
Net Profit
-14.29%-128.00M
-12.77%-106.00M
-46.74%-135.00M
100.00%0.00
-2700.00%-112.00M
-16.05%-94.00M
-29.58%-92.00M
-24.00%-93.00M
95.00%-4.00M
-20.08%-81.00M
-9.37%-71.00M
-12.56%-75.00M
-17.66%-80.00M
-124.15%-67.46M
16.74%-64.92M
12.29%-66.63M
6.34%-67.99M
638.77%279.37M
-4379.64%-77.97M
-68.55%-75.97M
Current assets
-18.14%844.00M
-0.89%1.01B
-23.96%857.00M
-7.44%946.00M
-3.10%1.03B
22.26%1.02B
27.78%1.13B
3.65%1.02B
4.83%1.06B
-22.12%831.00M
-19.90%882.00M
-19.67%986.00M
-19.71%1.01B
-15.43%1.07B
101.93%1.10B
64.55%1.23B
50.17%1.26B
71.48%1.26B
-31.60%545.29M
58.18%745.95M
Total current liabilities
8.85%209.00M
2.21%231.00M
9.30%235.00M
5.53%210.00M
-5.88%192.00M
22.83%226.00M
7.50%215.00M
10.56%199.00M
13.97%204.00M
-4.66%184.00M
12.88%200.00M
9.74%180.00M
11.00%179.00M
16.21%193.00M
24.02%177.18M
25.81%164.02M
22.11%161.25M
36.50%166.08M
-12.28%142.87M
225.72%130.37M
Total assets
-13.75%997.00M
-0.96%1.14B
-22.20%974.00M
-9.36%1.07B
-10.60%1.16B
5.02%1.15B
5.12%1.25B
-2.79%1.19B
3.11%1.29B
-18.59%1.09B
-14.55%1.19B
-17.39%1.22B
-18.75%1.25B
-15.51%1.34B
66.07%1.39B
64.31%1.48B
65.05%1.54B
106.13%1.59B
3.48%839.29M
86.70%898.77M
Total liabilities
-24.32%473.00M
-23.61%508.00M
-21.69%538.00M
-4.54%526.00M
6.66%625.00M
5.06%665.00M
2.38%687.00M
-15.75%551.00M
-10.40%586.00M
-7.99%633.00M
-3.47%671.00M
-10.34%654.00M
-12.43%654.00M
-8.32%688.00M
134.30%695.12M
147.91%729.39M
176.27%746.85M
177.96%750.45M
11.26%296.68M
458.51%294.22M
Total equity
-1.32%524.00M
30.10%631.00M
-22.83%436.00M
-13.54%549.00M
-24.89%531.00M
4.98%485.00M
8.65%565.00M
12.19%635.00M
17.83%707.00M
-29.68%462.00M
-25.58%520.00M
-24.27%566.00M
-24.68%600.00M
-21.92%657.00M
28.77%698.70M
23.63%747.39M
19.82%796.58M
67.52%841.45M
-0.33%542.61M
41.02%604.55M
Net operating income
-4.55%-138.00M
-20.00%-120.00M
-473.08%-97.00M
-41.49%-133.00M
-6500.00%-132.00M
-13.64%-100.00M
141.27%26.00M
-64.91%-94.00M
97.96%-2.00M
-26.18%-88.00M
22.18%-63.00M
12.71%-57.00M
-114.98%-98.00M
-12.30%-69.74M
-50.60%-80.96M
11.75%-65.30M
1086.19%654.00M
-24.50%-62.10M
-124.86%-53.76M
-209.11%-74.00M
Net investment
256.25%114.00M
-456.86%-182.00M
372.41%79.00M
117.46%137.00M
118.93%32.00M
82.14%51.00M
-363.64%-29.00M
142.31%63.00M
-231.01%-169.00M
-40.18%28.00M
-53.08%11.00M
112.08%26.00M
148.12%129.00M
147.49%46.81M
126.46%23.45M
-7266.07%-215.20M
-526.67%-268.06M
8287.88%18.91M
77.11%-88.61M
103.45%3.00M
Net financing
-97.89%3.00M
14400.00%286.00M
-83.33%8.00M
2500.00%52.00M
-37.99%142.00M
-166.67%-2.00M
700.00%48.00M
-91.30%2.00M
22800.00%229.00M
-73.20%3.00M
137.06%6.00M
429.22%23.00M
-93.30%1.00M
-4.08%11.20M
92.03%2.53M
94.80%4.35M
-93.28%14.93M
595.95%11.67M
-98.77%1.32M
-99.32%2.23M

FAQs

What is the total revenue of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its total revenue reached 247.00M, with a year-on-year change of 258.00M.

What are the current assets of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its current assets were 1.01B, with a year-on-year change of -0.89.

What are the total assets of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its total assets of Arcus Biosciences Inc were 1.14B, with a year-on-year change of -0.96.

What are the total liabilities of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its total liabilities of Arcus Biosciences Inc were 508.00M, with a year-on-year change of -23.61.

What is the total equity of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its total equity of Arcus Biosciences Inc was 631.00M, with a year-on-year change of 30.10.

What is the net operating income of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its net operating income of Arcus Biosciences Inc was -386.00M, with a year-on-year change of -24.52.

What is the net investment of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its net investment of Arcus Biosciences Inc was 66.00M, with a year-on-year change of 178.57.

What is the net financing of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its net financing of Arcus Biosciences Inc was 488.00M, with a year-on-year change of 76.17.

What is the Earnings Per Share (EPS) of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.29, with a year-on-year change of -4.64.

What is the net income of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its net income was -353.00M, with a year-on-year change of -24.73.

What is the net margin of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its net profit margin was -142.91, with a year-on-year change of -30.29.

What is the debt-to-asset ratio of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 8.69, with a year-on-year change of 108.24.

What is the Return on Equity (ROE) of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -63.26, with a year-on-year change of -5.85.

What is the Return on Assets (ROA) of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -30.84, with a year-on-year change of -22.34.

What is the operating profit of Arcus Biosciences Inc?

According to Arcus Biosciences Inc's FY2025 earnings report, its operating profit was -386.00M, with a year-on-year change of -24.52.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.